Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L. Reuteri for Pediatric Diarrhea in Peru
NCT02460575Phase 1Completed
- Sponsor
- Tulane University
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Lactobacillus reuteri DSM 17938 in diarrhea and Environmental Enteropathy (EED) (2 arms), sponsored by Tulane University. Primary endpoints: Number of Participants With Positive Blood Culture for L. Reuteri at 36 days and Mean Daily Temperature at 5 days. Started Jan 2019; status: completed.
02
Drugs
Lactobacillus reuteri DSM 17938
03
Conditions
diarrheaEnvironmental Enteropathy (EED)
Beyond the preview
Go deeper on NCT02460575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460575.